PT1250133E - Composicoes antialergicas oftalmicas adequadas a utilizacao com lentes de contacto - Google Patents

Composicoes antialergicas oftalmicas adequadas a utilizacao com lentes de contacto

Info

Publication number
PT1250133E
PT1250133E PT01906672T PT01906672T PT1250133E PT 1250133 E PT1250133 E PT 1250133E PT 01906672 T PT01906672 T PT 01906672T PT 01906672 T PT01906672 T PT 01906672T PT 1250133 E PT1250133 E PT 1250133E
Authority
PT
Portugal
Prior art keywords
compositions
contact lenses
antialergic
properties suitable
ophthalmic properties
Prior art date
Application number
PT01906672T
Other languages
English (en)
Portuguese (pt)
Inventor
John M Yanni
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of PT1250133E publication Critical patent/PT1250133E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
PT01906672T 2000-01-25 2001-01-24 Composicoes antialergicas oftalmicas adequadas a utilizacao com lentes de contacto PT1250133E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17780400P 2000-01-25 2000-01-25

Publications (1)

Publication Number Publication Date
PT1250133E true PT1250133E (pt) 2005-05-31

Family

ID=22650044

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01906672T PT1250133E (pt) 2000-01-25 2001-01-24 Composicoes antialergicas oftalmicas adequadas a utilizacao com lentes de contacto

Country Status (10)

Country Link
US (1) US6375973B2 (enExample)
EP (1) EP1250133B1 (enExample)
JP (2) JP2003520813A (enExample)
AT (1) ATE291913T1 (enExample)
AU (1) AU776789B2 (enExample)
CA (1) CA2395866C (enExample)
DE (1) DE60109742T2 (enExample)
ES (1) ES2236180T3 (enExample)
PT (1) PT1250133E (enExample)
WO (1) WO2001054687A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
US8388995B1 (en) 2006-02-03 2013-03-05 Auburn University Controlled and extended delivery of hyaluronic acid and comfort molecules via a contact lens platform
US8349352B2 (en) * 2005-02-04 2013-01-08 Auburn University Therapeutic contact lenses with anti-fungal delivery
WO2006084275A2 (en) * 2005-02-04 2006-08-10 Auburn University Contact drug delivery system
US9238003B2 (en) 2005-02-04 2016-01-19 Auburn University Extended or continuous wear silicone hydrogel contact lenses for the extended release of comfort molecules
US7947010B2 (en) 2005-07-08 2011-05-24 Depuy Products, Inc. Composition and system for wound decontamination
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
US20080138408A1 (en) * 2006-11-13 2008-06-12 Siddharth Venkatesh Drug delivery system and method
HUE026162T2 (en) * 2007-02-07 2016-05-30 Novartis Ag Olopatadine preparation for topical nasal administration
CN103140215A (zh) * 2010-07-21 2013-06-05 爱尔康研究有限公司 具有提高的溶解度特征的药物组合物
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠(olopatadine)眼用組成物
TW201336527A (zh) * 2012-02-10 2013-09-16 Alcon Res Ltd 具增強的穩定性之水性藥學組成物
WO2014150899A1 (en) * 2013-03-15 2014-09-25 Chapin Matthew J Topical ophthalmic formulations for treating migraine
WO2015065576A1 (en) * 2013-10-31 2015-05-07 Nephron Pharmaceuticals Corporation Formulation of olopatadine
EP3037094A1 (en) * 2014-12-23 2016-06-29 Poifa Warszawa SA Ophthalmic pharmaceutical composition
CN107875119B (zh) * 2017-11-22 2021-03-12 山东绅联药业有限公司 一种富马酸依美斯汀水性药物组合物及其制备方法
WO2025137749A1 (pt) * 2023-12-27 2025-07-03 Eurofarma Laboratórios S.A. Processo de solubilização de olopatadina e seu uso

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931319A (en) 1974-10-29 1976-01-06 Millmaster Onyx Corporation Capped polymers
US4027020A (en) 1974-10-29 1977-05-31 Millmaster Onyx Corporation Randomly terminated capped polymers
US4525346A (en) 1981-09-28 1985-06-25 Alcon Laboratories, Inc. Aqueous antimicrobial ophthalmic solutions
US4407791A (en) 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
JPS5879983A (ja) 1981-11-06 1983-05-13 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
US4836986A (en) 1984-09-28 1989-06-06 Bausch & Lomb Incorporated Disinfecting and preserving systems and methods of use
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
JPH08770B2 (ja) * 1985-12-25 1996-01-10 千寿製薬株式会社 眼科用組成物
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
US5037647A (en) * 1988-09-15 1991-08-06 Alcon Laboratories, Inc. Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride
US5192780A (en) 1989-12-18 1993-03-09 Alcon Laboratories, Inc. Methods using antiallergics and antihistamines
AU636685B2 (en) * 1989-12-18 1993-05-06 Alcon Laboratories, Inc. Compositions of antiallergics and antihistamines and methods for their use
US5145643A (en) 1990-01-05 1992-09-08 Allergan, Inc. Nonoxidative ophthalmic compositions and methods for preserving and using same
DE69333850T3 (de) 1992-05-06 2011-03-17 Alcon Laboratories, Inc., Fort Worth Anwendung von boral-polyol-komplexen für ophthalmische arzneizusammensetzungen
US5300287A (en) 1992-11-04 1994-04-05 Alcon Laboratories, Inc. Polymeric antimicrobials and their use in pharmaceutical compositions
JP3527256B2 (ja) 1992-12-09 2004-05-17 ロート製薬株式会社 抗アレルギー点眼剤
US5668133A (en) 1992-12-09 1997-09-16 Alcon Laboratories, Inc. Ophthalmic compositions comprising emedastine and methods for their use
US5370744B1 (en) * 1993-08-27 1999-11-09 Alcon Lab Inc Process for cleaning and disinfecting contact lenses
US5603929A (en) 1994-11-16 1997-02-18 Alcon Laboratories, Inc. Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
JP3297969B2 (ja) * 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
AU721273B2 (en) * 1996-09-20 2000-06-29 Bausch & Lomb Incorporated Method and composition for rewetting contact lenses and relieving eye dryness
ZA9811445B (en) * 1997-12-19 1999-08-16 Alcon Lab Inc Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions.
JP4545927B2 (ja) * 1998-04-07 2010-09-15 アルコン ラボラトリーズ, インコーポレイテッド キサンタンガムを含有するゲル化眼科用組成物
JP3407654B2 (ja) * 1998-04-14 2003-05-19 ライオン株式会社 眼科用組成物
US6146622A (en) * 1998-10-27 2000-11-14 Alcon Laboratories, Inc. Use of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions

Also Published As

Publication number Publication date
AU3455601A (en) 2001-08-07
DE60109742T2 (de) 2005-08-18
CA2395866A1 (en) 2001-08-02
AU776789B2 (en) 2004-09-23
EP1250133B1 (en) 2005-03-30
DE60109742D1 (de) 2005-05-04
WO2001054687A1 (en) 2001-08-02
ES2236180T3 (es) 2005-07-16
ATE291913T1 (de) 2005-04-15
CA2395866C (en) 2009-10-13
US20010056093A1 (en) 2001-12-27
EP1250133A1 (en) 2002-10-23
US6375973B2 (en) 2002-04-23
JP2003520813A (ja) 2003-07-08
JP2011132259A (ja) 2011-07-07

Similar Documents

Publication Publication Date Title
PT1250133E (pt) Composicoes antialergicas oftalmicas adequadas a utilizacao com lentes de contacto
FR2704327B1 (fr) Paire de lentilles ophtalmiques multifocales progressives.
DK1026533T3 (da) Progressive additionslinser med regressive overflader
BRPI0109443B1 (pt) hidrogel de silicone umectÁvel, lentes oftÁlmicas e mÉtodo de preparaÇço de um hidrogel de silicone.
DE60139390D1 (de) Binokulare linsensysteme
NO20032816D0 (no) Kontaktlinse med opakt irismönster
MXPA03004041A (es) Lentes oftalmicas sin union y metodos para su produccion.
BR0016386A (pt) Lentes oftálmicas multifocais birrefringentes refrativas hìbridas
ECSP044862A (es) Pirenzepine ophthalmic gel
NO981151D0 (no) Kontaktlinse med forhöyninger for öyelokk-kontakt
FR2803921B1 (fr) Jeu de deux lentilles ophtalmiques, gamme et procede pour constituer un tel jeu
AR031417A1 (es) Sistemas desinfectantes acuosos
NO20011396L (no) Öyebeskyttelse
AR034200A1 (es) Agente para el cuidado de lentes de contacto, su uso, y procedimiento de limpieza
WO2001007049A3 (en) Ophthalmic composition comprising ketotifen
AR027492A1 (es) Metodo para disenar y ajustar lentes de contacto tomando en cuenta las propiedades del material de las lentes.
DE60119166D1 (de) Monomerzusammensetzung, daraus erhaltenes polymer und okularlinse
FR2803922B1 (fr) Lentille ophtalmique
DK1445641T3 (da) Okulære linser
ATE257371T1 (de) Augenspüllösung
SE0001925D0 (sv) Methods of obtaining ophthalmic lenses capable of reducing the aberrations of the eye
ECSP992838A (es) Lente de contacto multifocal progresiva adecuada para compensacion de la presbiopia
IT1307972B1 (it) Perfezionamento di astina di occhiali con estremita' dotata di mollaelasticizzante.
BR9603465A (pt) Simulador dinâmico do cristalino ocular
DK1250133T3 (da) Oftalmiske anti-allergiske præparater egnet til anvendelse med kontaktlinser